self pay glp 1 Wegovy was $1500 for self-pay patients just a year ago. #Wegovy #WegovySavings #Semaglutide #GLP1 #WeightLossMedication #ObesityMedicine #EvidenceBasedWeightLoss #ScienceNotShame #ObesityIsADisease #MetabolicHealth #ChronicDiseaseCare #AffordableCare Ditch the hype. 📉 GLP-1

The FDA has issued warnings regarding certain compounded semaglutide and tirzepatide products, citing concerns related to purity, dosing accuracy, and contamination

Supply Chain Status GLP 1 medication availability, particularly for high demand products like semaglutide and tirzepatide, has experienced significant fluctuations

Liraglutide, a glucagon-like peptide-1 receptor agonist, inhibits bone loss in an animal model of osteoporosis with or without diabetes

PINK1-parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury

23 Still, the use of pharmacological antiobesity agents is considered experimental in women with PCOS when aimed at enhancing fertility, 24 thus opening new venues for clinical research on restoring fertility in obese PCOS patients

GLP-1 exists in two equipotent circulating peptides: GLP-1 (737) and GLP-1 (736) amide (27), with GLP-1 (736) amide being more abundant in the circulation after a meal (28)